The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5
- PMID: 29118766
- PMCID: PMC5662967
- DOI: 10.1159/000475846
The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5
Abstract
Lipopolysaccharide or endotoxin, the major cell wall component of gram-negative bacteria, plays a pivotal role in the pathogenesis of sepsis. It is able to activate the host defense system through the interaction with Toll-like receptor 4, thus triggering pro-inflammatory mechanisms. When the production of inflammatory mediators becomes uncontrolled and excessive, septic shock develops with multiple organ dysfunction, such as myocardial and renal impairment, which are hallmarks of cardiorenal syndrome type 5. In this review, we will analyze the role of endotoxin in the pathogenesis of sepsis, its effects on cardiac and renal interactions in the setting of cardiorenal syndrome type 5 and the possible use of extracorporeal therapies in this clinical condition.
Keywords: Cardiorenal syndrome type 5; Endotoxin; Lipopolysaccharide.
Figures
Similar articles
-
Endotoxin in Sepsis: Methods for LPS Detection and the Use of Omics Techniques.Diagnostics (Basel). 2022 Dec 27;13(1):79. doi: 10.3390/diagnostics13010079. Diagnostics (Basel). 2022. PMID: 36611371 Free PMC article. Review.
-
Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes.Blood Purif. 2017;44(4):314-326. doi: 10.1159/000480424. Epub 2017 Nov 22. Blood Purif. 2017. PMID: 29161706 Review.
-
Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation.Kidney Blood Press Res. 2016;41(6):1008-1015. doi: 10.1159/000452602. Epub 2016 Dec 23. Kidney Blood Press Res. 2016. PMID: 28006779
-
Pathophysiology and treatment of gram-negative sepsis.Am J Hosp Pharm. 1990 Nov;47(11 Suppl 3):S6-10. Am J Hosp Pharm. 1990. PMID: 2275478 Review.
-
Cardiorenal syndrome in sepsis: A narrative review.J Crit Care. 2018 Feb;43:122-127. doi: 10.1016/j.jcrc.2017.08.044. Epub 2017 Sep 1. J Crit Care. 2018. PMID: 28881261 Review.
Cited by
-
Lactobacillus casei relieves liver injury by regulating immunity and suppression of the enterogenic endotoxin-induced inflammatory response in rats cotreated with alcohol and iron.Food Sci Nutr. 2021 Aug 11;9(10):5391-5401. doi: 10.1002/fsn3.2486. eCollection 2021 Oct. Food Sci Nutr. 2021. PMID: 34646510 Free PMC article.
-
Range of adiposity and cardiorenal syndrome.World J Diabetes. 2020 Aug 15;11(8):322-350. doi: 10.4239/wjd.v11.i8.322. World J Diabetes. 2020. PMID: 32864046 Free PMC article. Review.
-
Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.J Nephrol. 2019 Oct;32(5):803-810. doi: 10.1007/s40620-019-00613-2. Epub 2019 Apr 20. J Nephrol. 2019. PMID: 31006081
-
Endotoxin in Sepsis: Methods for LPS Detection and the Use of Omics Techniques.Diagnostics (Basel). 2022 Dec 27;13(1):79. doi: 10.3390/diagnostics13010079. Diagnostics (Basel). 2022. PMID: 36611371 Free PMC article. Review.
-
Klotho downregulation contributes to myocardial damage of cardiorenal syndrome in sepsis.Mol Med Rep. 2020 Aug;22(2):1035-1043. doi: 10.3892/mmr.2020.11178. Epub 2020 May 22. Mol Med Rep. 2020. PMID: 32468073 Free PMC article.
References
-
- Ianaro A, Tersigni M, D'Acquisto F. New insight in LPS antagonist. Mini Rev Med Chem. 2009;9:306–317. - PubMed
-
- Tavener SA, et al. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia. Circ Res. 2004;95:700–707. - PubMed
-
- Wang X, Quinn PJ. Lipopolysaccharide: biosynthetic pathway and structure modification. Prog Lipid Res. 2010;49:97–107. - PubMed
-
- Hoshino K, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999;162:3749–3752. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources